News – Page 823 – Endpoints News

FDA kicks off GDUFA III reauthorization process

5 years ago

Can fully shutting down the estrogen receptor make a difference in breast cancer? Olema scores $54M to find out in ...

5 years ago

Cullinan Oncology launches new subsidiary focused on collagen-binding cytokine treatment

5 years ago

Covid-19 roundup: Pfizer/BioNTech’s Warp Speed deal means big money for two billionaire twins; Novavax lays out a ...

5 years ago

‘So is there a plan?’ Lawmakers grill Warp Speed developers, Pfizer and Merck on whether they can actually ...

5 years ago

Justice Department accuses Chinese hackers of targeting US biotechs in a cybertheft campaign aimed at stealing ...

5 years ago

GV's David Schenkein comes in to help mentor — and bankroll — a gene therapy 2.0 player, intrigued by their ...

5 years ago

A wobbly Biogen makes a surprise switch in the executive suite, triggering a renewed burst of M&A chatter

5 years ago

Covid-19 roundup: Top analyst pokes hole in AstraZeneca/Oxford data while scientists tamper hope for fast rollout

5 years ago

Elevation Oncology launches with $32.5 million Series A, gives new life to former Merrimack program

5 years ago

Pieris slammed with FDA hold; Biogen adds PhIV for Spinraza

5 years ago

Juno/WuXi's cell therapy venture buys out solid tumor player in China, gaining a discovery engine and portending more ...

5 years ago

Leo Pharma offloads a psoriasis asset as their Dupixent rival heads to the FDA

5 years ago

Gilead lines up a $1.55B biotech buyout deal as CEO Dan O’Day invests in his latest cancer blockbuster dream

5 years ago

GSK, Germany push coronavirus-focused mRNA player CureVac's latest round to $640M

5 years ago

Amplitude raises $50M to fuel ‘emerging’ Canadian biotech field

5 years ago

Novartis quietly buries another failed eczema drug, with a $485M hit embedded in the footnotes

5 years ago

Chris Garabedian's incubator leads Series A funding for gene therapy manufacturer/developer combo

5 years ago

Roche partners on a slate of Jnana's immunology, neurology targets, rewarding its faith in the SLC transporter class

5 years ago

Acadia’s shot at beating a ‘fickle’ major depression challenge misses the mark in a failed PhIII

5 years ago

Not just AstraZeneca — CanSino Biologics also unveils Phase II data, showing antibody and T cell response

5 years ago

AstraZeneca, Oxford researchers champion a one-two punch against Covid-19 in first human study

5 years ago

Amplyx touts upbeat readout from a small PhII study for lead antifungal

5 years ago

Small AI biotech BioXcel surges on positive PhIII results, setting up dementia and Alzheimer’s test

5 years ago

First page Previous page 820 821 822823824 825 826 Next page Last page